| PERIOD ENDING | 30-Nov-09 | 30-Nov-08 | 30-Nov-07 | | Total Revenue | 494,137 | 515,560 | 493,500 | | Cost of Revenue | 93,202 | 91,889 | 86,756 | | | Gross Profit | 400,935 | 423,671 | 406,744 | | | Operating Expenses | | Research Development | 93,262 | 87,788 | 80,345 | | Selling General and Administrative | 241,839 | 258,159 | 253,706 | | Non Recurring | 5,655 | 6,915 | 8,174 | | Others | 9,047 | 6,426 | 7,303 | | | | Total Operating Expenses | 349,803 | 359,288 | 349,528 | | | | Operating Income or Loss | 51,132 | 64,383 | 57,216 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | 9,627 | 7,831 | | Earnings Before Interest And Taxes | 51,180 | 74,010 | 65,047 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 51,180 | 74,010 | 65,047 | | Income Tax Expense | 18,425 | 27,714 | 22,767 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 32,755 | 46,296 | 42,280 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 32,755 | 46,296 | 42,280 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $32,755 | $46,296 | $42,280 |
|
1.52% Nasdaq 
Income Statement
